The latest Brexit row: UK s solo run has left the EU in a tricky position thejournal.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thejournal.ie Daily Mail and Mail on Sunday newspapers.
March 4, 2021 8:19 am
The EU will respond to the UK’s unilateral move on the Northern Ireland Protocol “in accordance with the legal means established by the Withdrawal Agreement and the Trade and Cooperation Agreement”, European Commission Vice-President Maroš Šefčovič has said.
Following the UK government’s statement today, Vice-President Šefčovič expressed the EU’s “strong concerns” over the UK’s unilateral action, which he said “amounts to a violation of the relevant substantive provisions of the Protocol on Ireland / Northern Ireland and the good faith obligation under the Withdrawal Agreement”.
This is the second time that the UK government is set to breach international law, he said, adding:
CLAIM “The priority order for [vaccinating] everybody has been the same no matter where you live across the UK… that’s been one of the strengths of the rollout…” – Matt Hancock, UK Health Secretary, March 4, 2021 DOORSTEP ANSWER Hancock is wrong. The “strength” of the vaccination rollout was that Scotland was able to do its own thing and opted to prioritise elderly care home residents who were the most vulnerable to the Covid-19 virus. Scotland achieved 100% cover for care home elderly ahead of England. BACKGROUND On Thursday, March 4, the Health Secretary visited the University of Glasgow Lighthouse Laboratory, which conducts Covid-19 tests. The Glasgow Lighthouse Lab is a favourite place for visiting Tory ministers to hold photo opportunities. The PM visited the Lighthouse just weeks ago as part of his “love-bombing” initiative.
EU will go to court over UK s unilateral action on Northern Ireland Protocol euronews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euronews.com Daily Mail and Mail on Sunday newspapers.
A team of UK scientists has recently evaluated the effectiveness of the Pfizer (BNT162b2) and AstraZeneca (ChAdOx1) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The findings reveal that both vaccines are effective in significantly reducing SARS-CoV-2 infection in older adults and providing long-term protection.